IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Casdin Capital, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 32 holdings | $278.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Codexis Inc(CDXS)COM192005106$81.1M5,073,78029.1%
Alnylam Pharmaceuticals Inc(ALNY)COM02043Q107$59.3M515,00021.3%
Biolife Solutions Inc(BLFS)COM NEW09062W204$39.9M2,468,57114.3%
Agios Pharmaceuticals Inc(AGIO)COM00847X104$39.4M825,00014.1%
Caredx Inc(CDNA)COM14167L103$25.9M1,200,0009.3%
Alector Inc(ALEC)COM014442107$18.5M1,076,0396.6%
Adaptive Biotechnologies COR(ADPT)COM00650F109$13.9M463,1255.0%
Sarepta Therapeutics Inc(SRPT)COM803607100$86.5K670,0000.0%
Bluebird BIO IncCOM09609G100$85.1K970,0000.0%
Blueprint Medicines Corp(2L9)COM09627Y109$75.3K940,0000.0%
Myokardia IncCOM62857M105$73.2K1,005,0000.0%
Invitae Corp(NVTA1EUR)COM46185L103$58.7K3,638,3880.0%
Constellation Pharmceticls I(CNST)COM210373106$57.1K1,212,7340.0%
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$51.5K860,0000.0%
Fate Therapeutics Inc(FATE)COM31189P102$49.9K2,550,0000.0%
Magenta Therapeutics IncCOM55910K108$47.0K3,098,1210.0%
Global Blood Therapeutics inCOM37890U108$23.8K300,0000.0%
Denali Therapeutics Inc(DNLI)COM24823R105$21.8K1,250,0000.0%
Fulcrum Therapeutics Inc(FULC)+COM359616109$20.6K1,239,2850.0%
Illumina Inc(ILMN)COM452327109$19.9K60,0000.0%
Gritstone Oncology Inc(2JQ)COM39868T105$19.4K2,160,0000.0%
Sage Therapeutics Inc(SG7)COM78667J108$16.6K230,0000.0%
Genmark Diagnostics Inc(GNMK)COM372309104$16.2K3,365,0000.0%
Deciphera Pharmaceuticals in(DCPHEUR)COM24344T101$15.9K255,0000.0%
Voyager Therapeutics Inc(VYGR)COM92915B106$15.3K1,095,0750.0%
Gilead Sciences Inc(GILD)CallCOM375558103$13.0K200,0000.0%
Sangamo Therapeutics Inc(SGMO)COM800677106$12.2K1,455,0000.0%
Orchard Therapeutics PLCADS68570P101$11.3K820,0000.0%
Twist Bioscience Corp(TWST)COM90184D100$6.3K300,0000.0%
Turning Point Therapeutics ICOM90041T108$4.7K75,0000.0%
Bristol Myers Squibb Co(BMY-R)RIGHT 99/99/9999110122157$4.5K1,500,0000.0%
Stoke Therapeutics Inc(STOK)COM86150R107$3.7K130,0000.0%